• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biotec Pharmacon ASA

+ Add to Watchlist

BPHAF:US

Price not available for BPHAF:US

Snapshot for Biotec Pharmacon ASA (BPHAF)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for BPHAF

No chart data available.
  • BPHAF:US
  • 1M
  • 1Y
0.0000
Interactive BPHAF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BPHAF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2014) -0.4300
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 43.51
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BPHAF

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for BPHAF

Biotec Pharmacon ASA develops, manufactures and markets immune modulating compounds for the human and animal health sectors and marine enzymes used in molecular biology. The Company develops products to prevent or treat diseases caused by the failure, imbalance, and over-reaction of the immune system.

Svein W F LienChief Executive OfficerArvid VangenCFO/CAO
Rolf EngstadCSO
More Company Profile & Key Executives for BPHAF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil